Gilteritinib overcomes lorlatinib resistance in ALK-rearranged cancer
暂无分享，去创建一个
Y. Okuno | Ryohei Katayama | M. Shirouzu | N. Fujita | J. Adachi | M. Nishio | K. Katayama | M. Araki | Yukari Sagae | N. Yanagitani | K. Tamai | Kana Watanabe | M. Kukimoto-Niino | L. Friboulet | S. Takagi | T. Oh‐hara | Biao Ma | S. Simizu | J. Kutkowska | Ai Takemoto | Y. Sasakura | Koutaroh Okada | H. Mizuta | Kohei Maruyama | Keiichi Tamai